Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cosmos HealthCOSM +6.61%24 3-Year FCF Growth Rate is 67.00% as of Jun. 2026. GuruFocus rates COSM with a GF Score™ of 24/100 and a GF Value™ of $0.28 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 76 Medical Distribution companies, Cosmos Health ranks better than 89.47% on this metric.
During the past 3 years, the average Free Cash Flow per Share Growth Rate was 67.00% per year.
During the past 5 years, the average Free Cash Flow per Share Growth Rate was 60.90% per year.
During the past 10 years, the average Free Cash Flow per Share Growth Rate was 16.80% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.
During the past 13 years, the highest 3-Year average Free Cash Flow per Share Growth Rate of Cosmos Health was 67.00% per year. The lowest was -79.90% per year. And the median was -8.20% per year.
Cosmos Health (NAS:COSM) 3-Year FCF Growth Rate Explanation
Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.
Cosmos Health 3-Year FCF Growth Rate Related Terms
COSM vs HKPD, YI, MEDS: 3-Year FCF Growth Rate Comparison
For the Medical Distribution subindustry, Cosmos Health's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cosmos Health 3-Year FCF Growth Rate vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Cosmos Health's 3-Year FCF Growth Rate distribution charts can be found below:
* The bar in red indicates where Cosmos Health's 3-Year FCF Growth Rate falls into.
This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.
What does a 3-Year FCF Growth Rate of 67.00% mean?
Cosmos Health (COSM) has a 3-Year FCF Growth Rate of 67.00% as of Jun. 2026. 3-Year FCF Growth Rate is the 3-year average growth rate of Free Cash Flow per Share. View historical data for Cosmos Health and its competitors. According to the industry distribution chart, Cosmos Health ranks #8 out of 76 companies in the Medical Distribution industry, placing it in the top 10.5%.
Is Cosmos Health's 3-Year FCF Growth Rate too high?
Cosmos Health's current 3-Year FCF Growth Rate is 67.00%. The Medical Distribution industry median 3-Year FCF Growth Rate is 8.40. Cosmos Health's value of 67.00% is 697.6% above this industry median. Based on the distribution chart, Cosmos Health ranks #8 out of 76 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Cosmos Health has a GF Score™ of 24/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cosmos Health's 3-Year FCF Growth Rate compare to HKPD and YI?
According to the Medical Distribution industry distribution chart, Cosmos Health ranks #8 out of 76 companies for 3-Year FCF Growth Rate. This places Cosmos Health in the top 11% of its industry — outperforming the majority of peers. The industry median 3-Year FCF Growth Rate is 8.40. Cosmos Health's value of 67.00% is 697.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year FCF Growth Rate for a Medical Distribution company?
The median 3-Year FCF Growth Rate among Medical Distribution companies is 8.40, based on 76 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year FCF Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year FCF Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cosmos Health's current 3-Year FCF Growth Rate of 67.00% is 697.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year FCF Growth Rate mean?
A high 3-Year FCF Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year FCF Growth Rate is the 3-year average growth rate of Free Cash Flow per Share. View historical data for Cosmos Health and its competitors. For the Medical Distribution industry, the median 3-Year FCF Growth Rate is 8.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cosmos Health's current 3-Year FCF Growth Rate is 67.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cosmos Health stock overvalued right now?
Based on GuruFocus' analysis, Cosmos Health (COSM) is currently considered Modestly Overvalued. The stock's GF Value™ is $0.28, compared to a current price of $0.33 — trading 17.5% above its estimated fair value. The current 3-Year FCF Growth Rate is 67.00% and 697.6% above the Medical Distribution industry median of 8.40. Cosmos Health's overall GF Score™ is 24/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year FCF Growth Rate calculated?
3-Year FCF Growth Rate is calculated from a company's financial statements. For Cosmos Health (COSM), the current 3-Year FCF Growth Rate is 67.00% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cosmos Health (COSM) Overvalued in 2026?
Based on GuruFocus' analysis, Cosmos Health stock appears to be overvalued.
The current stock price of $0.33 is trading 17.5% above its estimated GF Value™ of $0.28.
GuruFocus considers Cosmos Health to be Modestly Overvalued.
Key valuation signals for COSM:
3-Year FCF Growth Rate: 67.00%
GF Value™: $0.28 vs. price of $0.33 (17.5% above fair value)
Industry Position: 697.6% above the Medical Distribution median (#8 of 76)
No single metric tells the full story. See the COSM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cosmos Health Inc is a diversified, vertically integrated healthcare group, owner of proprietary pharmaceutical and nutraceutical brands, generics, manufacturer and distributor of healthcare products, engaged in research & development of medicines and repurposing drugs as well as operator of a telehealth platform. The company has developed its own proprietary branded nutraceutical products, named 'Sky Premium Life' and 'Mediterranation'. Its product portfolio includes generics and over-the-counter pharmaceutical products, medicines, as well as nutraceuticals and biocides. The company's Reportable segments are Wholesale, Pharma manufacturing, and Nutraceutical and pharmaceuticals, with the majority of revenue generated from the Wholesale segment.
24GF Score
Get the complete analysis for COSM
3-Year FCF Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
COSM has been successfully added to your 
